Additionally, pyrvinium pamoate stimulated the increased transcription of a number of pro-apoptotic ATF4 target genes, including NOXA, PUMA and CHOP [80] further supporting the potential for modulation of the ISR as a therapeutic strategy for hematologic malignancies. The gene discussed is PMAIP1; the disease is hematologic disorder.